Morgan Stanley Sees Attractive Risk/Reward for Medtronic - Medtronic (NYSE:MDT)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

In a report published Wednesday, Morgan Stanley analyst David R. Lewis reiterated an Overweight rating and $73.00 price target on Medtronic (NYSE: MDT).In the report, Morgan Stanley noted, “The pipeline is driving growth and stronger EM and improving margins should bolster fundamentals through the year. Despite noise on inversion, we believe the deal will go through. Growth and shareholder returns are going higher and at 13x pro forma cash EPS, we see an attractive risk reward.”Medtronic closed on Tuesday at $64.01.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!